Carpmaels & Ransford LLP

Dispute Resolution

Andrew is a partner in the firm’s Dispute Resolution team, with 20 years’ experience handling disputes before the UK courts, CJEU, UPC and EPO. Andrew is an expert in managing and coordinating global cross-border patent litigation. With his biotechnology and biochemistry background, Andrew advises clients on complex patent, SPC and regulatory problems, supported by his insights from committee positions in industry organisations. According to IAM Patent, he is a “life sciences maven”.

Andrew is a seasoned patent litigator and strategic advisor for pharma and biotech clients. He has utilised his strong technical background – having studied Natural Sciences (Biochemistry) at Cambridge, Christ’s College – to advise clients litigating patents before all courts in the UK, including the UK IPO, Patents Court, Court of Appeal and Supreme Court, as well as the Court of Justice of the European Union.

His experience includes a number of leading small molecule and biologic drug cases for Bayer, Eli Lilly, LEO Pharma and GSK, as well as disputes concerning medical devices, additive manufacturing, cosmetics, consumer products and industrial manufacturing.

Andrew also understands and advises clients on regulatory matters, in particular relating to supplementary protection certificates (SPCs). This is supported by insights from Andrew’s roles sitting on IP advisory committees for industry organisations, such as the UK Biotech Industry Association and US Intellectual Property Owners Association. Andrew has also been involved in consultations concerning reforms of SPC and regulatory law.

Andrew’s expertise and experience extends beyond the UK, advising clients involved in almost every dimension of parallel disputes, including coordinating timelines and case spanning courts and patent offices in the UK, Europe, US and across the globe.

Andrew has applied his experience to advise clients on the new dimension added by the powerful forum of the Unified Patent Court (UPC), handling disputes at the fringes of developing rules and caselaw, and providing strategic advice on areas such as pinning patents (out and in), complex jurisdictional issues and cross-border enforcement.

Andrew joined Carpmaels & Ransford in 2025 having trained, qualified and practised at two international firms based in London.

Andrew came to patent law having studied Natural Sciences at Cambridge (Christ’s College), specialising in Biochemistry (including researching the role of amphiphysin in the development of mammalian skeletal muscle tissue as part of his MSci).

MSci, MA Natural Sciences (Biochemistry) (University of Cambridge, Christ’s College) LPC, PgDL (Nottingham Law School) Solicitor Diploma in Intellectual Property Law & Practice (Bristol University)